Works in Oncology Research, 2024, Vol 32, Issue 11

Results: 19

Retraction: MicroRNA-1277 inhibits proliferation and migration of hepatocellular carcinoma HepG2 cells by targeting and suppressing BMP4 expression and reflects the significant indicative role in hepatocellular carcinoma pathology and diagnosis after magnetic resonance imaging assessment

Published in:: 2024
Publication type:: Correction Notice

Retraction: MicroRNA-374a promotes hepatocellular carcinoma cell proliferation by targeting mitogen-inducible gene 6 (MIG-6).

Published in:: 2024
Publication type:: Correction Notice

Retraction: Long noncoding RNA urothelial carcinoma-associated 1 promotes the proliferation and metastasis of human lung tumor cells by regulating MicroRNA-144.

Published in:: 2024
Publication type:: Correction Notice

Retraction: Long noncoding RNA GAS5 promotes proliferation, migration, and invasion by regulation of miR-301a in esophageal cancer.

Published in:: 2024
Publication type:: Correction Notice

Retraction: long noncoding RNA CAT104 promotes cell viability, migration, and invasion in gastric carcinoma cells through activation of microRNA-381-inhibiting zinc finger e-box-binding homeobox 1 (ZEB1) expression.

Published in:: 2024
Publication type:: Correction Notice

Retraction: long noncoding RNA ATB promotes proliferation, migration, and invasion in bladder cancer by suppressing microRNA-126.

Published in:: 2024
Publication type:: Correction Notice

Retraction: long noncoding RNA ANRIL promotes cervical cancer development by acting as a sponge of miR-186.

Published in:: 2024
Publication type:: Correction Notice

Retraction: lncRNA C2dat1 promotes cell proliferation, migration, and invasion by targeting miR-34a-5p in osteosarcoma cells.

Published in:: 2024
Publication type:: Correction Notice

Retraction: Downregulation of microRNA-135 promotes sensitivity of non-small cell lung cancer to gefitinib by targeting TRIM16.

Published in:: 2024
Publication type:: Correction Notice

Retraction: Ailanthone promotes human vestibular schwannoma cell apoptosis and autophagy by downregulation of miR-21.

Published in:: 2024
Publication type:: Correction Notice

Redefining the tumor microenvironment with emerging therapeutic strategies.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1701, doi. 10.32604/or.2024.055161

By:

XU, SULING;
LI, XIAO;
MA, WENXUE

Publication type:

Article

Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1709, doi. 10.32604/or.2024.053972

By:

MODI, SHAIL RAKESH;
ANDEY, TERRICK

Publication type:

Article

Unveiling the therapeutic potential: KBU2046 halts triple-negative breast cancer cell migration by constricting TGF-β1 activation in vitro.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1791, doi. 10.32604/or.2024.049348

By:

CHEN, JINXIA;
DAI, SULI;
ZHANG, GENG;
WEI, SISI;
ZHAO, XUETAO;
ZHENG, YANG;
WANG, YAOJIE;
WANG, XIAOHAN;
LIU, YUNJIANG;
ZHAO, LIANMEI

Publication type:

Article

MiR-150-5p inhibits cell proliferation and metastasis by targeting FTO in osteosarcoma.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1777, doi. 10.32604/or.2024.047704

By:

XU, LICHEN;
ZHANG, PAN;
ZHANG, GUIQI;
SHEN, ZHAOLIANG;
BAI, XIZHUANG

Publication type:

Article

Epidemiological and clinical characteristics of lung cancer in Saudi Arabia: a retrospective study in single oncology center.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1803, doi. 10.32604/or.2024.052358

By:

KATIB, YOUSEF;
MULLA, NASSER

Publication type:

Article

Is ypTNM staging a comparable predictor as pTNM staging for survival in non-metastatic rectal cancer after preoperative chemoradiation therapy?

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1723, doi. 10.32604/or.2024.052098

By:

CHUANG, JEN-PIN;
TSAI, HSIANG-LIN;
SU, WEI-CHIH;
CHEN, PO-JUNG;
HUANG, CHING-WEN;
CHANG, TSUNG-KUN;
CHEN, YEN-CHENG;
LI, CHING-CHUN;
YEH, YUNG-SUNG;
YIN, TZU-CHIEH;
WANG, JAW-YUAN

Publication type:

Article

Integrative bioinformatics and in vitro exploration of EVI2A expression: unraveling its immunological and prognostic implications in kidney renal clear cell carcinoma.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1733, doi. 10.32604/or.2024.050851

By:

LIU, RONG;
LI, SHENG;
XIONG, SITU;
ZHENG, FUCUN;
ZHAN, XIANGPENG;
ZENG, JIN;
FU, BIN;
XU, SONGHUI;
ZHU, SHAOXING;
CHEN, RU

Publication type:

Article

Remodeling tumor microenvironment using pH-sensitive biomimetic co-delivery of TRAIL/R848 liposomes against colorectal cancer.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1765, doi. 10.32604/or.2024.045564

By:

HUANG, YONGJIAN;
WANG, JINZHOU;
XU, JIUHUA;
RUAN, NING

Publication type:

Article

CircTIAM1 overexpression promotes the progression of papillary thyroid cancer by regulating the miR-338-3p/LASP1 axis.

Published in:

Oncology Research, 2024, v. 32, n. 11, p. 1747, doi. 10.32604/or.2024.030945

By:

ZHANG, YE;
LIANG, YANAN;
WU, YAN;
SONG, LIWEN;
ZHANG, ZUWANG

Publication type:

Article